基本情報
| サイトトップ | https://glaukos.com |
|---|
HTMLサイズ
| 1ページ平均HTML（バイト） | 239800.1 |
|---|
内部リンク集計
| リンク総数 | 14 |
|---|
外部リンク集計
| リンク総数 | 177 |
|---|
メタ情報
| meta description平均長 | 135.33 |
|---|---|
| OGPありページ数 | 10 |
| Twitterカードありページ数 | 10 |
HTML言語 分布
| キー | 割合 |
|---|---|
| en-us | 100.00% |
文字コード 分布
| キー | 割合 |
|---|---|
| utf-8 | 100.00% |
内部リンク分析（Internal）
| ユニーク内部リンク数 | 14 |
|---|---|
| ページあたり内部リンク平均 | 4.9 |
内部リンク 深さヒストグラム
| キー | 値 |
|---|---|
| 1 | 16 |
| 2 | 25 |
| 3 | 2 |
| 5 | 6 |
内部リンク 上位URL
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|---|
| cross | 1 |
| riboflavin | 0.695652 |
| linking | 0.683021 |
| our | 0.674102 |
| phosphate | 0.521739 |
| solution | 0.521739 |
| collagen | 0.478261 |
| employees | 0.435423 |
| off | 0.434783 |
| IOP | 0.434783 |
| keratoconus | 0.422822 |
| corneal | 0.404688 |
| ocular | 0.396051 |
| FDA | 0.393226 |
| epithelium | 0.391304 |
| procedure | 0.391304 |
| approved | 0.357773 |
| intracameral | 0.347826 |
| clinical | 0.325248 |
| progressive | 0.325248 |
| will | 0.325248 |
| not | 0.321792 |
| may | 0.311017 |
| Foundation | 0.304348 |
| following | 0.304348 |
| use | 0.304348 |
| intraocular | 0.304348 |
| pressure | 0.304348 |
| angle | 0.304348 |
| Our | 0.292723 |
| System | 0.292723 |
| have | 0.272285 |
| team | 0.26087 |
| philanthropic | 0.26087 |
| insurance | 0.26087 |
| dextran | 0.26087 |
| side | 0.26087 |
| effects | 0.26087 |
| device | 0.26087 |
| administration | 0.26087 |
| other | 0.260198 |
| Charitable | 0.248813 |
| Talent | 0.248813 |
| Acquisition | 0.248813 |
| search | 0.248813 |
| using | 0.248813 |
| payers | 0.248813 |
| Retinal | 0.248813 |
| Disease | 0.248813 |
| Research | 0.248813 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|---|---|---|
| iStent | inject | 4.268947 | 140 |
| Mobius | trademark | 3.943583 | 80 |
| Mobius | Therapeutics | 3.879853 | 75 |
| Transforming | Vision | 3.829343 | 80 |
| Photrexa | Viscous | 3.728317 | 124 |
| registered | trademarks | 3.710336 | 160 |
| iAccess | infinite | 3.676924 | 80 |
| cross | linking | 3.621232 | 80 |
| KXL | system | 3.471185 | 85 |
| ophthalmic | solution | 3.374296 | 54 |
| iAccess | iLink | 3.334369 | 80 |
| phosphate | riboflavin | 3.298955 | 49 |
| iStent | infinite | 3.261977 | 96 |
| KXL | Viscous | 3.254036 | 88 |
| Therapeutics | trademark | 3.211595 | 60 |
| Vision | iDose | 3.190569 | 80 |
| effects | side | 3.169107 | 32 |
| phosphate | solution | 3.164202 | 42 |
| keratoconus | progressive | 3.134305 | 40 |
| Mitosol | trademark | 3.095813 | 60 |
| ophthalmic | phosphate | 3.083399 | 48 |
| intraocular | pressure | 3.060587 | 28 |
| Mitosol | company | 3.043598 | 80 |
| Corporation | Glaukos | 3.008554 | 192 |
| common | most | 2.836448 | 24 |
| Avedro | trademarks | 2.785619 | 80 |
| riboflavin | solution | 2.771034 | 39 |
| refractive | surgery | 2.679024 | 20 |
| Viscous | system | 2.664391 | 63 |
| FDA | approved | 2.664383 | 40 |
| ophthalmic | riboflavin | 2.647007 | 44 |
| Mitosol | registered | 2.631023 | 80 |
| registered | trademark | 2.631023 | 80 |
| Disease | Retinal | 2.628224 | 16 |
| fortunate | less | 2.601605 | 16 |
| Acquisition | Talent | 2.601605 | 16 |
| encouraged | report | 2.601605 | 16 |
| Visit | www | 2.601605 | 16 |
| fda | www | 2.601605 | 16 |
| fda | gov | 2.601605 | 16 |
| gov | medwatch | 2.601605 | 16 |
| indicates | required | 2.601605 | 16 |
| fields | required | 2.601605 | 16 |
| cell | endothelial | 2.601605 | 16 |
| Disease | Research | 2.601605 | 16 |
| Charitable | Foundation | 2.589395 | 20 |
| infinite | inject | 2.580366 | 60 |
| long | term | 2.573015 | 20 |
| collagen | cross | 2.555231 | 40 |
| Transforming | iDose | 2.539807 | 60 |